The mission of the Georgetown Lombardi Comprehensive Cancer Center's (LCCC) Administration is to facilitate and implement LCCC's vision and create, support, and sustain an environment that fosters research, interactivity, and optimal productivity of Cancer Center investigators and adds value to the Center. Supporting 4 Research Programs, 9 Shared Resources and 91 members focused on basic, translational, clinical, and population-based research, Administration oversees $30M in grants and contracts (direct costs). Headed by Michael Vander Hoek, MHSA, Associate Director (AD) for Administration, the administrative team supports LCCC leadership planning, strategic investments, benchmarking and evaluation, and communication with constituencies. In addition to building an experienced management team to support Cancer Center members, Vander Hoek managed the recruitment of several key LCCC leaders including the Deputy Director, AD for Clinical Research, and the Codirector of the Biostatistics &Bioinformatics Shared Resource (SR) and supported the faculty appointments and promotions of several SR Directors and Research Program members. He and his team have successfully managed institutional commitments to support these strategic initiatives. Administration tracks and manages LCCC's $25M per year in institutional investments from the University and MedStar Health, ensuring investments are linked to LCCC's Strategic Plan. Administration documents and executes LCCC policies on membership, pilot funding, equipment purchases. Shared Resources and space. During this period. Administration supported opening a community office for health disparities research in one of the most underserved areas ofthe District of Columbia. Cancer research education and training are also coordinated by Administration. Significant expansion of administrative activities have supported an increasingly productive relationship with our MedStar Health clinical partner in strengthening a clinical network aimed at increasing accrual to therapeutic trials and increasing the diversity of individuals enrolling on trials. For example. Administration negotiated a research agreement to expand and strengthen the clinical research organizational structure across the Georgetown MedStar Cancer Network creating an integrated Clinical Research Management Office (ICRMO). Other activities are highlighted within the narrative. The CCSG budget requested represents 6.6% of the total LCCC administrative budget and represents 7.6% ofthe total CCSG budget.

Public Health Relevance

Lombardi Administration advances the vision of Cancer Center leaders in a thriving environment that supports, evaluates and sustains research activities that are innovative, transformative, collaborative and well organized.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA051008-21
Application #
8698929
Study Section
Subcommittee G - Education (NCI)
Project Start
1997-08-15
Project End
2019-04-30
Budget Start
2014-09-09
Budget End
2015-04-30
Support Year
21
Fiscal Year
2014
Total Cost
$156,713
Indirect Cost
$45,154
Name
Georgetown University
Department
Type
DUNS #
049515844
City
Washington
State
DC
Country
United States
Zip Code
20057
Laiakis, Evagelia C; Mak, Tytus D; Strawn, Steven J et al. (2018) Global metabolomic responses in urine from atm deficient mice in response to LD50/30 gamma irradiation doses. Environ Mol Mutagen 59:576-585
O'Neill, Suzanne C; Taylor, Kathryn L; Clapp, Jonathan et al. (2018) Multilevel Influences on Patient-Oncologist Communication about Genomic Test Results: Oncologist Perspectives. J Health Commun 23:679-686
Kim, Sang-Soo; Harford, Joe B; Moghe, Manish et al. (2018) Targeted nanocomplex carrying siRNA against MALAT1 sensitizes glioblastoma to temozolomide. Nucleic Acids Res 46:1424-1440
Wallington, Sherrie; Oppong, Bridget; Dash, Chiranjeev et al. (2018) A Community-Based Outreach Navigator Approach to Establishing Partnerships for a Safety Net Mammography Screening Center. J Cancer Educ 33:782-787
Wärri, Anni; Cook, Katherine L; Hu, Rong et al. (2018) Autophagy and unfolded protein response (UPR) regulate mammary gland involution by restraining apoptosis-driven irreversible changes. Cell Death Discov 4:40
Pohlmann, Paula R; Isaacs, Claudine (2018) Extended Adjuvant Endocrine Therapy for Postmenopausal Women: Treating Many to Benefit a Few. J Natl Cancer Inst 110:
Fu, Ying; Silverstein, Shana; McCutcheon, Justine N et al. (2018) An endogenous DNA adduct as a prognostic biomarker for hepatocarcinogenesis and its prevention by Theaphenon E in mice. Hepatology 67:159-170
Stires, Hillary; Heckler, Mary M; Fu, Xiaoyong et al. (2018) Integrated molecular analysis of Tamoxifen-resistant invasive lobular breast cancer cells identifies MAPK and GRM/mGluR signaling as therapeutic vulnerabilities. Mol Cell Endocrinol 471:105-117
Xiao, David; Zheng, Chaoyi; Jindal, Manila et al. (2018) Medicaid Expansion and Disparity Reduction in Surgical Cancer Care at High-Quality Hospitals. J Am Coll Surg 226:22-29
Kozlik, Petr; Goldman, Radoslav; Sanda, Miloslav (2018) Hydrophilic interaction liquid chromatography in the separation of glycopeptides and their isomers. Anal Bioanal Chem 410:5001-5008

Showing the most recent 10 out of 1120 publications